OLIGOMETASTATIC DISEASE
Clinical trials for OLIGOMETASTATIC DISEASE explained in plain language.
Never miss a new study
Get alerted when new OLIGOMETASTATIC DISEASE trials appear
Sign up with your email to follow new studies for OLIGOMETASTATIC DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo treatment may slow colorectal cancer spread
Disease control OngoingThis trial is for people with colorectal cancer that has spread to a few spots in the body but cannot be fully removed by surgery alone. After 3-4 months of standard chemotherapy, participants either continue chemotherapy alone or also receive local ablative therapy—such as surge…
Matched conditions: OLIGOMETASTATIC DISEASE
Phase: NA • Sponsor: Australasian Gastro-Intestinal Trials Group • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New drug cocktail aims to stall returning prostate cancer
Disease control OngoingThis study looks at men whose prostate cancer has come back in a few spots (oligometastatic) and who have certain gene mutations. It compares standard care (hormone therapy plus radiation) against the same treatment plus a 6-month course of two drugs (niraparib and abiraterone wi…
Matched conditions: OLIGOMETASTATIC DISEASE
Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New combo therapy aims to halt spread of prostate cancer
Disease control OngoingThis phase 2 study tests a combination of radiation, hormone therapy (ADT), and two drugs (abiraterone and olaparib) in 21 men with prostate cancer that has spread to a few spots in the body. The goal is to see if this approach can prevent the cancer from growing or spreading fur…
Matched conditions: OLIGOMETASTATIC DISEASE
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC